80537-08-2

Basic information

• Product Name: Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2-Methyl-
• Synonyms: Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2-Methyl-;2-Methylpyrazolo[1,5-a]pyridine-3-carboxylic acid
• CAS NO: 80537-08-2
• Molecular Formula: C₉H₈N₂O₂
• Molecular Weight: 176.17202
• Mol File: 80537-08-2.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2-Methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2-Methyl-(80537-08-2)
• EPA Substance Registry System: Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 2-Methyl-(80537-08-2)

Safety Data

• Hazardous Substances Data: 80537-08-2(Hazardous Substances Data)

Upstream product

• 30843-10-8 2-methyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid ethyl ester 
• 6295-87-0 N-aminopyridin-1-ium iodide 
• 23326-27-4 Methyl 2-butynoate 
• 4341-76-8 Ethyl 2-butynoate 
• 110-86-1 pyridine 

Downstream Products

• 80537-06-0 2-Methyl-pyrazolo[1,5-a]pyridine-3-carboxylic acid [2-(2-hydroxy-ethyl)-phenyl]-amide 
• 1610966-00-1 5-fluoro-N-(4-methoxyphenyl)-2-(2-methylpyrazolo[1,5-a]pyridin-3-yl)pyrimidine-4,6-diamine 
• 1542710-61-1 N-benzyl-2-{2-methylpyrazolo[1,5-a]pyridin-3-yl}-5,6,7,8-tetrahydroquinazolin-4-amine 

Relevant articles and documents

ANTIBACTERIAL COMPOUNDS

The present invention relates to the following compounds, wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis.

Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents

A series of pyrazolo[1,5-a]pyridine-3-carboxamide derivatives were designed and synthesized as new anti-Mycobacterium tuberculosis (Mtb) agents. The compounds exhibit promising in vitro potency with nanomolar MIC values against the drug susceptive H37Rv s

SUBSTITUTED PYRIMIDINE BMI-1 INHIBITORS

Amine substituted pyrimidine compounds and forms thereof that inhibit the function and reduce the level of B -cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein and methods for their use to inhibit Bmi-1 function and reduce the